Precision NanoSystems Wins BC Export Award for Emerging Exporter

Press Release

November 25, 2015

Vancouver, BC, Canada –

Precision NanoSystems Inc. (PNI) was awarded the BC Export Award for Emerging Exporter. Nominees are deemed to be the “best of the best” of their respective sector and demonstrate significant contributions to the BC economy through economic growth in their community, new investment and job creation. The Emerging Exporter Award recognizes a company that has made its initial entry into an export market and achieved notable success. The award acknowledges the company’s ability to overcome obstacles in order to expand its potential markets and grow its business through export.

“It is an honour to be selected as this year’s winner in the Emerging Exporter category,” said James Taylor, Co-Founder & CEO of Precision NanoSystems. “Past winners of the BC Export Awards have gone on to receive international recognition and receiving this award reinforces our strategy to continually strive for international growth.”

About Precision NanoSystems, Inc.

Precision NanoSystems, Inc. (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI’s proprietary NanoAssemblr platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.

About the BC Export Awards

The BC Export Awards are the province’s most prestigious awards paying tribute to the success and innovative approaches of BC export companies.  Extending across industries the awards recognize achievements in 12 different categories and are a celebration of the contributions exporters have made to both the provincial and national economy. Conceived in 1982, the program has recognized over 300 companies since its inception, reflecting the growth and diversity of BC’s economy over the past 30 years.


Press Release

CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials

Read More

Press Release

Precision Nanosystems Inc. (PNI), announced today that they have entered into a manufacturing collaboration agreement with Evonik Canada for the tech transfer of the NanoAssemblr Scale-Up system to Evonik Vancouver Laboratories (VAN) for the manufa...

Read More